1sbg: Difference between revisions

New page: left|200px<br /> <applet load="1sbg" size="450" color="white" frame="true" align="right" spinBox="true" caption="1sbg, resolution 2.3Å" /> '''AN ORALLY-BIOAVAILAB...
 
No edit summary
Line 1: Line 1:
[[Image:1sbg.gif|left|200px]]<br />
[[Image:1sbg.gif|left|200px]]<br /><applet load="1sbg" size="350" color="white" frame="true" align="right" spinBox="true"  
<applet load="1sbg" size="450" color="white" frame="true" align="right" spinBox="true"  
caption="1sbg, resolution 2.3&Aring;" />
caption="1sbg, resolution 2.3&Aring;" />
'''AN ORALLY-BIOAVAILABLE HIV-1 PROTEASE INHIBITOR CONTAINING AN IMIDAZOLE-DERIVED PEPTIDE BOND REPLACEMENT. CRYSTALLOGRAPHIC AND PHARMACOKINETIC ANALYSIS'''<br />
'''AN ORALLY-BIOAVAILABLE HIV-1 PROTEASE INHIBITOR CONTAINING AN IMIDAZOLE-DERIVED PEPTIDE BOND REPLACEMENT. CRYSTALLOGRAPHIC AND PHARMACOKINETIC ANALYSIS'''<br />


==Overview==
==Overview==
(2R,4S,5S,1'S)-2-Phenylmethyl-4-hydroxy-5-(tert-butoxycarbonyl), amino-6-phenylhexanoyl-N-(1'-imidazo-2-yl)-2'-methylpropanamide (compound, 2) is a tripeptide analogue inhibitor of HIV-1 protease in which a, C-terminal imidazole substituent constitutes an isoelectronic, structural, mimic of a carboxamide group. Compound 2 is a potent inhibitor of the, protease (K(i) = 18 nM) and inhibits HIV-1 acute infectivity of CD4+, T-lymphocytes (IC50 = 570 nM). Crystallographic analysis of an HIV-1, protease-compound 2 complex demonstrates that the nitrogen atoms of the, imidazole ring assume the same hydrogen-bonding interactions with the, protease as amide linkages in other peptide analogue inhibitors. The sole, substitution of the C-terminal carboxamide of a hydroxyethylene-containing, tripeptide analogue with an imidazole group imparts greatly improved, pharmacokinetic and oral bioavailability properties on the compound, compared to its carboxamide-containing homologue (compound 1). While the, oral bioavailability of compound 1 in rats was negligible, compound 2, displayed oral bioavailabilities of 30% and 14%, respectively, in rats and, monkeys.
(2R,4S,5S,1'S)-2-Phenylmethyl-4-hydroxy-5-(tert-butoxycarbonyl) amino-6-phenylhexanoyl-N-(1'-imidazo-2-yl)-2'-methylpropanamide (compound 2) is a tripeptide analogue inhibitor of HIV-1 protease in which a C-terminal imidazole substituent constitutes an isoelectronic, structural mimic of a carboxamide group. Compound 2 is a potent inhibitor of the protease (K(i) = 18 nM) and inhibits HIV-1 acute infectivity of CD4+ T-lymphocytes (IC50 = 570 nM). Crystallographic analysis of an HIV-1 protease-compound 2 complex demonstrates that the nitrogen atoms of the imidazole ring assume the same hydrogen-bonding interactions with the protease as amide linkages in other peptide analogue inhibitors. The sole substitution of the C-terminal carboxamide of a hydroxyethylene-containing tripeptide analogue with an imidazole group imparts greatly improved pharmacokinetic and oral bioavailability properties on the compound compared to its carboxamide-containing homologue (compound 1). While the oral bioavailability of compound 1 in rats was negligible, compound 2 displayed oral bioavailabilities of 30% and 14%, respectively, in rats and monkeys.


==About this Structure==
==About this Structure==
1SBG is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Human_immunodeficiency_virus_type_1_(isolate_bh10) Human immunodeficiency virus type 1 (isolate bh10)] with IM1 as [http://en.wikipedia.org/wiki/ligand ligand]. Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1SBG OCA].  
1SBG is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Human_immunodeficiency_virus_type_1_(isolate_bh10) Human immunodeficiency virus type 1 (isolate bh10)] with <scene name='pdbligand=IM1:'>IM1</scene> as [http://en.wikipedia.org/wiki/ligand ligand]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1SBG OCA].  


==Reference==
==Reference==
Line 19: Line 18:
[[Category: hydrolase(acid protease)]]
[[Category: hydrolase(acid protease)]]


''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Thu Nov  8 14:28:24 2007''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 14:59:45 2008''

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA, Eric Martz